| pubmed-article:20947926 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20947926 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:20947926 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
| pubmed-article:20947926 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:20947926 | lifeskim:mentions | umls-concept:C0442034 | lld:lifeskim |
| pubmed-article:20947926 | lifeskim:mentions | umls-concept:C0024623 | lld:lifeskim |
| pubmed-article:20947926 | lifeskim:mentions | umls-concept:C0027627 | lld:lifeskim |
| pubmed-article:20947926 | lifeskim:mentions | umls-concept:C0144576 | lld:lifeskim |
| pubmed-article:20947926 | lifeskim:mentions | umls-concept:C0039593 | lld:lifeskim |
| pubmed-article:20947926 | lifeskim:mentions | umls-concept:C0022885 | lld:lifeskim |
| pubmed-article:20947926 | lifeskim:mentions | umls-concept:C0282460 | lld:lifeskim |
| pubmed-article:20947926 | lifeskim:mentions | umls-concept:C2723351 | lld:lifeskim |
| pubmed-article:20947926 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:20947926 | pubmed:dateCreated | 2011-1-28 | lld:pubmed |
| pubmed-article:20947926 | pubmed:abstractText | Owing to its peculiar pharmacological characteristics, paclitaxel attains substantial intra-peritoneal concentration for a prolonged period when delivered intra-peritoneally, and is active against peritoneal metastasis of ovarian cancer. It is also considered promising against disseminated gastric cancer. However, the fact that the intra-peritoneal paclitaxel has not been approved in Japan has rendered its evaluation by a formal clinical trial impossible. The authors designed a randomized phase II trial using the Kodo Iryo Hyoka system, a new system to legally test an yet unapproved mode of treatment. It is hoped that this trial will result in a breakthrough in the treatment of peritoneal carcinomatosis from gastric cancer. | lld:pubmed |
| pubmed-article:20947926 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20947926 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20947926 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20947926 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20947926 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20947926 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20947926 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:20947926 | pubmed:issn | 1465-3621 | lld:pubmed |
| pubmed-article:20947926 | pubmed:author | pubmed-author:NakaoAkimasaA | lld:pubmed |
| pubmed-article:20947926 | pubmed:author | pubmed-author:KoderaYasuhir... | lld:pubmed |
| pubmed-article:20947926 | pubmed:author | pubmed-author:TakahashiNaot... | lld:pubmed |
| pubmed-article:20947926 | pubmed:author | pubmed-author:SasakoMitsuru... | lld:pubmed |
| pubmed-article:20947926 | pubmed:author | pubmed-author:SakamotoJunic... | lld:pubmed |
| pubmed-article:20947926 | pubmed:author | pubmed-author:YoshikawaTaka... | lld:pubmed |
| pubmed-article:20947926 | pubmed:author | pubmed-author:TsuburayaAkir... | lld:pubmed |
| pubmed-article:20947926 | pubmed:author | pubmed-author:MoritaSatoshi... | lld:pubmed |
| pubmed-article:20947926 | pubmed:author | pubmed-author:ImanoMotohiro... | lld:pubmed |
| pubmed-article:20947926 | pubmed:author | pubmed-author:MiyashitaYumi... | lld:pubmed |
| pubmed-article:20947926 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20947926 | pubmed:volume | 41 | lld:pubmed |
| pubmed-article:20947926 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20947926 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20947926 | pubmed:pagination | 283-6 | lld:pubmed |
| pubmed-article:20947926 | pubmed:dateRevised | 2011-4-20 | lld:pubmed |
| pubmed-article:20947926 | pubmed:meshHeading | pubmed-meshheading:20947926... | lld:pubmed |
| pubmed-article:20947926 | pubmed:meshHeading | pubmed-meshheading:20947926... | lld:pubmed |
| pubmed-article:20947926 | pubmed:meshHeading | pubmed-meshheading:20947926... | lld:pubmed |
| pubmed-article:20947926 | pubmed:meshHeading | pubmed-meshheading:20947926... | lld:pubmed |
| pubmed-article:20947926 | pubmed:meshHeading | pubmed-meshheading:20947926... | lld:pubmed |
| pubmed-article:20947926 | pubmed:meshHeading | pubmed-meshheading:20947926... | lld:pubmed |
| pubmed-article:20947926 | pubmed:meshHeading | pubmed-meshheading:20947926... | lld:pubmed |
| pubmed-article:20947926 | pubmed:meshHeading | pubmed-meshheading:20947926... | lld:pubmed |
| pubmed-article:20947926 | pubmed:meshHeading | pubmed-meshheading:20947926... | lld:pubmed |
| pubmed-article:20947926 | pubmed:meshHeading | pubmed-meshheading:20947926... | lld:pubmed |
| pubmed-article:20947926 | pubmed:meshHeading | pubmed-meshheading:20947926... | lld:pubmed |
| pubmed-article:20947926 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:20947926 | pubmed:articleTitle | A randomized phase II trial to test the efficacy of intra-peritoneal paclitaxel for gastric cancer with high risk for the peritoneal metastasis (INPACT trial). | lld:pubmed |
| pubmed-article:20947926 | pubmed:affiliation | Department of Surgery II, Nagoya University Graduate School of Medicine, 63 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan. ykodera@med.nagoya-u.ac.jp | lld:pubmed |
| pubmed-article:20947926 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20947926 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:20947926 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:20947926 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:20947926 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
